Recommended DNT Reference Chemical Test Set For In Vitro Assay Development*

Abstract New approach methodologies (NAMs) for developmental neurotoxicology are being developed and used to provide information on chemical hazard and risk for humans while limiting the use of animals. Recently OECD published an initial guidance document for use of the Developmental Neurotoxicity In Vitro Battery (DNT IVB), composed of in vitro assays that assess critical neurodevelopmental processes. To evaluate assay performance and develop new assays for inclusion in the DNT IVB, positive and negative control compounds with known actions neurodevelopmental processes are required. In contrast, to evaluate the ability of the battery of in vitro DNT assays to predict developmental neurotoxicity in vivo in mammals (and particularly in humans), a different set of positive and negative controls are required. These are DNT Reference Chemicals ‐ chemicals with evidence for in vivo developmental neurotoxicity identified in studies of humans or experimental animals (positives), as well as chemicals with evidence that they do not result in developmental neurotoxicity in vivo (negatives). The OECD guidance proposed a draft list of approximately 100 chemicals for use as DNT Reference Chemicals. The importance of this common set of chemicals was to provide a basis for beginning the evaluation of the current DNT‐IVB performance vs. the available in vivo DNT studies and determine the added value of possible new assays developed for inclusion in the DNT IVB. The purpose of the current report is to update Appendix A of OCED 337 (OECD, 2023) and provide a Recommended DNT Reference Chemical Test Set for use in in vitro DNT assay development and evaluation.

Authors

Publication Details

Journal
EFSA Supporting Publications
Published
2024-12-01
DOI
https://doi.org/10.2903/sp.efsa.2024.en-9175
Citations
3
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
3.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recommended DNT Reference Chemical Test Set For In Vitro Assay Development*

William R. Mundy, Kevin M. Crofton
3 citations
EFSA Supporting Publications
Pharmaceutical studies and practices
3.33
article

Recommended DNT Reference Chemical Test Set For In Vitro Assay Development*

William R. Mundy, Kevin M. Crofton
article en
3 citations

Abstract

Abstract New approach methodologies (NAMs) for developmental neurotoxicology are being developed and used to provide information on chemical hazard and risk for humans while limiting the use of animals. Recently OECD published an initial guidance document for use of the Developmental Neurotoxicity In Vitro Battery (DNT IVB), composed of in vitro assays that assess critical neurodevelopmental processes. To evaluate assay performance and develop new assays for inclusion in the DNT IVB, positive and negative control compounds with known actions neurodevelopmental processes are required. In contrast, to evaluate the ability of the battery of in vitro DNT assays to predict developmental neurotoxicity in vivo in mammals (and particularly in humans), a different set of positive and negative controls are required. These are DNT Reference Chemicals ‐ chemicals with evidence for in vivo developmental neurotoxicity identified in studies of humans or experimental animals (positives), as well as chemicals with evidence that they do not result in developmental neurotoxicity in vivo (negatives). The OECD guidance proposed a draft list of approximately 100 chemicals for use as DNT Reference Chemicals. The importance of this common set of chemicals was to provide a basis for beginning the evaluation of the current DNT‐IVB performance vs. the available in vivo DNT studies and determine the added value of possible new assays developed for inclusion in the DNT IVB. The purpose of the current report is to update Appendix A of OCED 337 (OECD, 2023) and provide a Recommended DNT Reference Chemical Test Set for use in in vitro DNT assay development and evaluation.

EFSA Supporting PublicationsVol. 21(12)
Openalex Percentile: Top 7%
Pharmaceutical studies and practices
3.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.